IN BRIEF: Polarean Imaging expands Xenon MRI imaging platform

Polarean Imaging PLC - medical imaging technology developer - announces the successful expansion ...

Alliance News 10 March, 2025 | 8:34PM
Email Form Facebook Twitter LinkedIn RSS

Polarean Imaging PLC - medical imaging technology developer - announces the successful expansion of a new imaging service model to enable the use of Xenon MRI in pharma-sponsored research, alongside its partner VIDA Diagnostics. This coincides with its selection by a leading global pharmaceutical partner to utilise the new Xenon MRI clinical trial support services platform as part of a sub-study within a worldwide multicentre study trial testing an investigational lung therapy.

Current stock price: 1.25 pence, up 2.0% in London on Monday

12-month change: down 70%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Polarean Imaging PLC Ordinary Shares 1.25 GBX 2.04 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures